Category Archives: News

Lilavati Hospital Uplifts Spirit Of Children with Festive Joy, Gifts, and Happiness

Mumbai: Christmas is a time to come together, extending love, care, and warmth to everyone. Carrying forward its legacy of giving back to society, Lilavati Hospital remains committed to rolling out life-changing initiatives, for the happiness of the underprivileged. By truly embodying the festive spirit of togetherness and goodwill, the Hospital organized a delightful Christmas celebration for children from Rural Ashram schools and those who have undergone cochlear implant surgeries. Over 300 children from Rural Ashram schools and 100 cochlear implant recipients, OPD, and IPD patients were part of the joyous occasion filled with fun activities, dance, exciting gifts, and scrumptious snacks. Present on the occasion were the board of trustees along with the management team who gave their blessings to the children and wished them a brighter future filled with hope and positivity.

The Hospital hosted a grand Christmas celebration for children with activities such as a magic show, dancing, and a photography session. Santa Claus made a special appearance, spreading cheer and creating unforgettable memories for the children.

Over 300 children from Rural Ashram schools based in the Palghar district of Maharashtra became the heart of the celebration as they traveled to Mumbai to Lilavati Hospital. For many, the journey to the bustling city and its towering buildings was a mix of excitement and nervousness. However, the engaging activities organized at the hospital created a warm and welcoming environment, helping the children unwind. Their faces lit up with joy as they embraced the experience, making the celebration truly memorable for everyone involved.

Shri. Rajiv Mehta, Permanent Trustee of Lilavati Hospital said, “The Christmas celebration is not just about the festivities but aims to uplift marginalized sections of society. By combining healthcare excellence with community-based campaigns and initiatives, the hospital is out and out to make a difference in the lives of countless individuals.”

Shri. Prashant Mehta, Permanent Trustee, Lilavati Hospital underscored, “This Christmas celebration will foster a sense of community and joy among these children. At Lilavati Hospital, we go beyond healthcare to create a holistic environment where every child feels supported, loved, and empowered. The celebrations were held under the thoughtful guidance of Smt. Charu Mehta, Founder and Permanent Trustee, whose leadership and vision. We hope to build confidence in children, nurture their dreams, and equip them to face life’s challenges with courage.”

“This event is a reminder that every child deserves an equal chance to thrive, and we are honored to play a part in making that a reality. Such initiatives are designed to lay a strong foundation for a brighter and inclusive future for everyone. We strive further to launch crucial path-breaking initiatives for improving the quality of life of those in need,” highlighted Dr Niraj Uttamani, Chief Operating Officer at Lilavati Hospital & Research Centre, Bandra.

“We were elated to welcome children from Rural Ashram schools who visited Mumbai for the very first time. The opportunity to host them at Lilavati Hospital allowed us to create an environment where they felt comfortable and cherished. It was a privilege to be a part of their journey and to give them an experience that brought so much positivity and warmth into their lives,” concluded Shri. Mohit Mathur, Permanent Trustee, Lilavati Hospital

Diabetes Myths vs. Facts: Clearing Up Common Misconceptions

By -Dr. Khushali Lalcheta, Consultant Physician, HCG Hospitals, Rajkot

 Diabetes is often a misunderstood condition that impacts various lives worldwide in different age groups. Managing diabetes requires careful lifestyle adjustments, from monitoring blood sugar to balancing diet and exercise. However, the journey of living with diabetes is often complicated by widespread myths and misconceptions, which can create confusion, stigma, and added challenges.

 These myths can lead to unnecessary restrictions or a lack of support from family and friends, making it harder for people with diabetes to manage their health effectively. By addressing and debunking these myths, we can foster a better understanding of diabetes and support those affected in leading healthier, empowered lives. Here’s a look at some of the most prevalent myths about diabetes and the facts that can help clarify them.

 Myth 1: Only People Who Are Overweight or Eat Poorly Get Diabetes
Fact: Diabetes is a complicated disease that is influenced by a combination of lifestyle, environmental, and hereditary variables, even though nutrition and weight can be risk factors. Diabetes type 1 is an autoimmune disease that often manifests in childhood or early adulthood and has nothing to do with diet or weight. Often identified in adults, type 2 diabetes is more closely associated with diet and lifestyle choices, although it can also strike those who lead active lives and maintain a healthy weight, especially if they have a family history of the disease.

 Myth 2: Eating Too Much Sugar Causes Diabetes
Fact: Consuming sugar alone does not directly cause diabetes. However, diets high in sugary and processed foods can lead to weight gain, which may increase the risk of developing Type 2 diabetes over time. For people with diabetes, managing carbohydrate intake, including sugar, is crucial to keep blood sugar levels stable, but consuming sugar in moderation is not necessarily harmful.

 Myth 3: People with Diabetes Can’t Eat Carbs or Sweets
Fact: People with diabetes do not need to avoid all carbs or sweets but they have to practice portion control and consume nutrient-rich foods that have a low impact on blood sugar. Carbohydrates are an essential part of a balanced diet, and many diabetics incorporate them healthily. Complex carbs like whole grains, vegetables, and fruits are slower to raise blood sugar and provide lasting energy. When it comes to sweets, moderation is the guiding principle.

 Myth 4: Diabetes Is Not a Serious Condition
Fact: Diabetes is a serious condition that, if left unmanaged, can lead to complications like heart disease, kidney disease, nerve damage, and vision problems. However, with effective management including medication, lifestyle adjustments, and regular monitoring many people with diabetes live long, healthy lives.

 Myth 5: People with Diabetes Should Avoid Physical Activity
Fact: Physical activity is highly beneficial for people with diabetes, as it helps manage blood sugar levels, improve cardiovascular health, and maintain a healthy weight. While certain activities may require adjustments in insulin or other medication doses, exercise is a powerful tool for diabetes management.

How End-to-End R&D Solutions are Enhancing Data Capture and Collaboration for Drug Development

The increasing complexity of scientific research, particularly in the field of drug development, necessitates sophisticated approaches to data capture and collaboration. In the context of biosimilars and generic drug development in India, the efficient management of data has become critical. The intricate processes involved in developing these drugs require meticulous data collection and analysis to ensure safety, efficacy, and regulatory compliance.

 Moreover, collaboration among various stakeholders—ranging from research institutions to pharmaceutical companies—is crucial. Effective communication and teamwork within a company are equally important, as multiple departments such as R&D, regulatory affairs, and clinical operations must align seamlessly to overcome challenges. This collaboration enhances the quality and speed of drug development, enabling more effective responses to the unique challenges faced in the Indian pharmaceutical landscape. Advanced data management solutions play a pivotal role in streamlining these processes, ensuring that data is not only captured accurately but also shared and analysed efficiently, ultimately driving innovation in drug development.

 These advancements are vital for India’s generics pharmaceutical industry, which is rapidly becoming a global hub for biosimilar and generic drug production.

 The Importance of End-to-End R&D Solutions

End-to-end R&D solutions are comprehensive systems designed to streamline the entire research and development process. These solutions integrate various stages of drug development, from data capture and analysis to collaboration and regulatory compliance, into a unified workflow. By connecting different aspects of R&D, such as data management, experimentation, and communication, these systems eliminate silos and enhance efficiency. This integration allows for smoother transitions between stages, reduces the risk of errors, and accelerates the overall development timeline. Ultimately, end-to-end R&D solutions are essential in modern drug development, driving innovation and improving the quality of research outcomes.

 Introduction to Signals Research Suite
Signals Research Suite offers an advanced end-to-end R&D workflow solution that revolutionises how research and development processes are conducted in the pharmaceutical industry. Signals Research Suite offers a comprehensive platform for data capture, collaboration, data processing, and data-driven analytics, all within a unified, cloud-native environment.

 Key features of Signals Research Suite include the ability to seamlessly integrate data from various stages of R&D, ensuring that researchers can capture, organise, and analyse data efficiently. The platform also facilitates collaboration across different teams and disciplines, enhancing communication and accelerating the drug development process. By providing robust data visualisation and analytics capabilities, the solution empowers researchers to make informed decisions quickly, ultimately leading to faster and more innovative drug development outcomes.

 Integrated Make-Test-Decide Workflows

The Make-Test-Decide workflow is a comprehensive approach that integrates disciplines such as biology, chemistry, and formulation to streamline drug development and enable researchers to design experiments, test hypotheses, and make informed decisions efficiently. Within Signals Research Suite, this innovation cycle is powered by industry-leading tools including ChemDraw and Spotfire®, which enhance visualisation and data analysis. ChemDraw simplifies the representation of chemical structures, while Spotfire offers advanced analytics, enabling researchers to gain deeper insights from their data. These tools are seamlessly embedded within the suite, ensuring a unified, end-to-end workflow that enhances data analysis, visualisation, and collaboration, ultimately accelerating the R&D process.

Enhancing Collaboration and Innovation

Signals Research Suite empowers researchers by providing a unified software platform that enhances collaboration across various R&D disciplines. This platform enables seamless integration of real-time experimental planning and laboratory bench work, ensuring that all teams are aligned and can share information effortlessly. By facilitating comprehensive data analytics, Signals Research Suite allows researchers to make informed decisions quickly, driving innovation and accelerating the pharmaceutical R&D process. The ability to adapt to changing experimental needs and integrate diverse data sources makes Signals Research Suite a vital tool for fostering collaboration and advancing scientific discoveries.

Benefits of Intelligent R&D and Formulation Data Management

 Intelligent R&D and formulation data management solutions significantly enhance the efficiency and effectiveness of drug development, particularly in the biosimilar and generic drug sectors in India. These solutions streamline workflows by integrating data across various stages of research and development, which is crucial for optimising synthesis and formulation processes. This integration not only helps in meeting customers’ unmet needs but also reduces costs and accelerates time to market.

 In India’s rapidly growing biosimilar market, advanced data management tools are essential for maintaining competitiveness and ensuring the successful development of new drugs. By leveraging these tools, Indian pharmaceutical companies can improve their chances of success in the global market, delivering high-quality, affordable medications more efficiently.

 General Benefits of End-to-End R&D Solutions in Development.

End-to-end R&D solutions offer numerous benefits in the development of new drugs by enhancing data capture and collaboration across research teams. These solutions streamline research processes, allowing for the integration of data from various stages of development, which leads to more informed decision-making and faster progression from research to market. By optimising workflows and reducing redundancies, end-to-end R&D platforms help accelerate the delivery of new products, improving overall efficiency and reducing costs. This approach not only expedites the journey of new drugs to market but also enhances the quality and reliability of research outcomes.

In conclusion, end-to-end R&D solutions play a crucial role in enhancing data capture and collaboration, driving innovation in drug development. As India continues to grow in biosimilar and generic drug production, integrated R&D platforms will be key to maintaining competitiveness, improving efficiency, and accelerating the delivery of high-quality, affordable medications to market.

Paw Petisserie Launches Its First-Ever Pet Café in Gurgaon

Gurgaon, December 26, 2024: Paw Petisserie is thrilled to announce the opening of its very first café in the heart of Gurgaon, offering a one-of-a-kind experience for pets and their parents alike. Unlike typical pet-friendly cafés, Paw Petisserie raises the bar with an elaborate menu crafted to delight both furry customers and their human companions.

The newly launched café serves a diverse array of options for everyone. For pets, the menu boasts gluten-free delights, while humans can enjoy dishes. From eggs to sandwiches, small plates to hearty large plates, every item on the human menu has a pet-friendly counterpart. Now, you and your pet can share the joy of dining together in a warm, welcoming atmosphere.

To make this festive season even more special, Paw Petisserie is rolling out exclusive Christmas-themed food options and bakery treats. These will be available on December 25th, promising a holiday experience filled with joy, love, and delicious indulgence for you and your beloved pets.

“We’ve created a space where pets and their parents can bond over great food, comfort, and an unparalleled sense of community,” said Yashika Arora founder of Paw Petisserie. “This café is all about celebrating the special relationship between humans and their pets, and we can’t wait to welcome you all.”

Magniflex India Spreads Holiday Joy Through A Heartwarming Christmas Collection Drive

Bengaluru, 26th December, 2024: Magniflex India (Made in Italy), Europe’s no. 1 mattress brand, organised MagnifleXmas, a special annual Christmas collection drive, across its franchise outlets in Bangalore, Hyderabad, Mumbai, Ahmedabad, and Delhi, and a prominent social club in Bangalore. This heartwarming initiative invited people to donate toys,
sweaters, and stationery for underprivileged children, fostering the spirit of giving during the festive season. Christmas bags were placed at various locations, creating a cheerful collection point for contributions. Through this initiative Magniflex India brought communities together to spread joy and comfort this holiday season.

Communities across the country rallied in overwhelming support for the initiative. Notably, members of the Bangalore Club displayed great generosity by donating a large number of gifts to the campaign. These sincere gifts were distributed at Makkala Jagriti, a Bengaluru-based NGO dedicated to nurturing the joy and creativity of underprivileged children. Mr. Anand Nichani, Managing Director of Magniflex India, personally presented the Christmas gifts, creating a heartfelt moment for the children. The event continued with a delightful tea and snacks, fostering meaningful connections and making the celebration truly memorable.

Reflecting on the initiative, Mr. Anand Nichani said, “The MagnifleXmas drive is a beautiful reminder of the joy that comes from giving. As we celebrate our third year of this initiative, I am truly inspired by the growing support from our community, which has resulted in an increasing number of gifts collected each year. Each gift, accompanied by a heartfelt message of love and hope, embodies the true essence of Christmas. This festive season is about creating opportunities for meaningful connections, and I am grateful to lead an initiative that continues to make a positive impact in the lives of those who need it most.”

MagnifleXmas drive not only showcased the power of collective goodwill but also reinforced Magniflex India’s commitment to creating meaningful change through community engagement. By bringing smiles to children and fostering a sense of togetherness, this initiative truly captured the spirit of the festive season.

Unocoin Celebrates 11 Years of Driving Cryptocurrency Innovation in India

New Delhi, India: December 26, 2024: Unocoin, India’s first cryptocurrency exchange platform, is proud to announce its 11th year anniversary, marking more than a decade of innovation, perseverance, and dedication to financial emancipation in India. Unocoin was founded in 2013 by Sathvik Vishwanath and Sunny Ray, and it has grown from a visionary notion to a cornerstone of India’s cryptocurrency ecosystem, pioneering developments that have altered the country’s digital finances.

The Unocoin story began as a blog created by Sunny Ray, a Canadian-born visionary captivated by Bitcoin’s potential to redefine finance. During a community forum in Bangalore, Sunny met Sathvik Vishwanath, a tech-savvy entrepreneur who expressed his vision for digital currency. Together, they took Unocoin from a passion project to India’s first cryptocurrency exchange, creating the groundwork for a robust crypto industry.

Unocoin has pioneered various initiatives that contributed to India’s cryptocurrency industry. The platform offered Indians with their first secure and user-friendly cryptocurrency exchange, allowing them to safely purchase, sell, and store digital assets. Its Bitcoin wallet services have become a popular tool for cryptocurrency aficionados, allowing for easy handling of digital money. Unocoin has bridged the gap between digital assets and the real economy by incorporating cryptocurrencies into merchant payment systems, opening up new opportunities for businesses and consumers alike.

Reflecting on this milestone, Mr. Sathvik Vishwanath, Co-founder and CEO of Unocoin, said:

“It has been an incredible journey filled with challenges and triumphs. Over the past 11 years, Unocoin has not only led the cryptocurrency revolution in India but has also remained steadfast in its mission to bring financial freedom to millions of Indians. We thank our users, partners, and supporters for being an integral part of our story.”

Unocoin’s 11th anniversary is a celebration of its accomplishments and a commitment to its aim of advancing financial inclusion in India. With thanks to its users, partners, and sponsors, Unocoin is ready to lead the next chapter in India’s digital finance evolution.

4 Early Symptoms of Colon Cancer Young Adults Should Know

By-Dr Nikhil Mehta, Consultant Surgical Oncologist, HCG Cancer Centre, Jaipur

Colon cancer, traditionally considered a condition affecting older adults, has been increasingly diagnosed in younger individuals. According to the American Cancer Society, cases among adults under 50 have been steadily rising, making it critical for younger demographics to recognize early symptoms. Detecting colon cancer early can significantly improve outcomes. Here are four key warning signs every young adult should be aware of:

 1. Persistent Changes in Bowel Habits
Unusual changes in bowel movements, such as chronic diarrhea, constipation, or alternating between the two, can be early indicators of colon cancer. Pay attention if these changes persist for more than a few weeks or if stools appear narrower than usual. Such changes may suggest a blockage or growth in the colon.

 2. Blood in Stool or Rectal Bleeding
Noticing blood in the stool, whether bright red or darker in color, is a red flag that should never be ignored. While conditions like hemorrhoids can also cause rectal bleeding, persistent blood in stool warrants immediate medical evaluation. This symptom can signal tumors in the colon or rectum.

 3. Unexplained Weight Loss
Unexpected weight loss without any changes to diet or exercise routines could be an early sign of colon cancer. As the cancer progresses, it may impact the body’s ability to absorb nutrients, leading to significant weight loss. This symptom often accompanies a loss of appetite or fatigue.

 4. Abdominal Pain and Discomfort
Frequent abdominal cramping, bloating, or a feeling of fullness even after eating small meals may indicate colon cancer. These symptoms could result from blockages or inflammation caused by tumors in the digestive tract.

 What Should You Do?
If you notice any of these symptoms persisting for more than two weeks, consult a healthcare professional immediately. Early screenings, such as colonoscopies or stool-based tests, can help detect precancerous polyps or cancer in its early stages.

 How to Reduce Your Risk
• Adopt a Healthy Diet: Eat plenty of fiber-rich foods, fruits, and vegetables while limiting red and processed meats.
• Stay Active: Regular exercise can help reduce the risk of colon cancer.
• Avoid Smoking and Excessive Alcohol Consumption: Both are linked to a higher risk of colorectal cancer.
• Know Your Family History: If you have a family history of colon cancer, consider starting screenings earlier.

 Treatment Options
Treatment often depends on the stage of the disease and individual factors like overall health. Some common treatment approaches include:

 1. Surgery
• Polypectomy or Local Excision: If detected early, small, localized tumors or polyps can be removed during a colonoscopy.
• Colectomy: For more advanced cases, a portion of the colon may be removed, and the healthy parts are reconnected.
• Colostomy: In cases where reconnection isn’t possible, an opening (stoma) is created for waste elimination.
2. Radiation Therapy – Often used for rectal cancer or advanced colon cancer, radiation therapy uses high-energy rays to destroy cancer cells and shrink tumors.
3. Chemotherapy – Involves drugs that kill or inhibit the growth of cancer cells. It is typically recommended after surgery if cancer has spread to nearby lymph nodes or beyond.
4. Targeted Therapy – Drugs like monoclonal antibodies or small molecules are designed to target specific proteins or genes involved in cancer growth. These therapies are effective in advanced or metastatic cases.
5. Immunotherapy – Utilises the body’s immune system to identify and attack cancer cells, often in cases with specific genetic markers, such as mismatch repair deficiency.
Colon cancer in young adults is a growing concern, but early awareness and proactive steps can make all the difference. By staying vigilant and prioritizing your health, you can reduce your risk and detect potential issues early.

Year Ending Quotes 2024 by Experts – F&B Sector

By-Vikesh Shah, Founder, 99 Pancakes

 “Reflecting on this year, I couldn’t be prouder of the growth and evolution we’ve experienced as a company. We set ambitious goals, many of which we surpassed, while others have provided us with invaluable lessons. Our team’s relentless dedication to pushing boundaries and adapting to new challenges has made this year one of our most transformative yet. As we enter the New Year, our commitment to innovation, customer-centricity, and operational excellence remains stronger than ever. The journey is only just beginning, and I’m excited for what lies ahead.”

By-Simranjeet Singh, Director, CYK Hospitalities

2024 witnessed a shift towards concept-driven dining, where unique themes and curated experiences became the core of F&B success. At CYK Hospitalities, we specialized in crafting bespoke concepts that resonated with evolving consumer preferences, blending innovation with authenticity. This year highlighted how a strong concept can turn a restaurant into a destination

By-Nidhi Singh, Co-founder, Samosa Singh – Quote as an F&B Industry Thought Leader

The food and beverage sector in 2024 has been a year of innovation and growth, as the industry embraced digital transformation and a return to roots with authentic yet healthier offerings. While we anticipated a focus on sustainability and consumer-centric solutions, the surge in global interest for Indian cuisine reaffirmed the timeless appeal of our culinary heritage. It’s an exciting time for the industry, with tradition and innovation coalescing like never before.

By-Shikhar Veer Singh, Co-founder, Samosa Singh, Quote as the Founder of Samosa Singh:

2024 has been a defining year for Samosa Singh. We revamped our manufacturing capabilities, scaling production capacity by 5x to meet growing demand. Entering Global markets and continuing our expansion across fueled with growth and customer love are some of the significant milestones that underscore our mission to bring India’s beloved snacks to a global stage. These achievements are a testament to the dedication of our team and the trust of our customers. As we gear up for 2025, we are excited to build on this momentum and continue to innovate in the food industry.